Cboe Global Markets Future Growth
Future criteria checks 2/6
Cboe Global Markets's revenue is forecast to decline at 9.8% per annum while its annual earnings are expected to grow at 6.6% per year. EPS is expected to grow by 8.5% per annum. Return on equity is forecast to be 21.9% in 3 years.
Key information
6.6%
Earnings growth rate
8.5%
EPS growth rate
Capital Markets earnings growth | 12.4% |
Revenue growth rate | -9.8% |
Future return on equity | 21.9% |
Analyst coverage | Good |
Last updated | 17 Jan 2025 |
Recent future growth updates
Recent updates
Cboe Global Markets: Rich Valuation, But High Quality Business And Strong Chart
Oct 29Dividend Printer Cboe - Capitalizing On Market Turmoil
Aug 06Cboe Global: Strong Exchange Delivers On A Solid Performance
May 27Cboe Global Markets: Revisiting One Of The Best Compounders In Finance
Mar 10Cboe Global Markets: This Countercyclical Stock Deserves A Place In Your Portfolio
Jan 10Cboe Global Markets: A Defensive Blue Chip Buy
Oct 30The Reasons I Like Cboe Global Markets
Aug 23Cboe Global Markets Is A Financial Dividend Growth Gem
Jul 18Cboe: Muted Growth Prospects
Jun 15Cboe Global Markets: Leveraging Global Growth And Access To Multi-Asset Activities
May 23Cboe Global Markets declares $0.50 dividend
Feb 09Cboe Global Markets Q4 2022 Earnings Preview
Feb 02Cboe multiply-listed options ADV slides 9% in December, gains over 7% from a year ago
Jan 05Cboe Global Markets: Quality Exchange Operator With Robust Fundamentals
Dec 07Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 2,326 | 953 | 1,008 | 1,085 | 3 |
12/31/2026 | 2,264 | 919 | 979 | 1,049 | 13 |
12/31/2025 | 2,164 | 877 | 943 | 1,012 | 14 |
12/31/2024 | 2,073 | 771 | 896 | 998 | 15 |
9/30/2024 | 3,956 | 776 | 1,568 | 1,622 | N/A |
6/30/2024 | 3,809 | 766 | 2,888 | 2,937 | N/A |
3/31/2024 | 3,743 | 793 | 901 | 940 | N/A |
12/31/2023 | 3,774 | 758 | 1,031 | 1,076 | N/A |
9/30/2023 | 3,810 | 706 | 1,067 | 1,121 | N/A |
6/30/2023 | 3,894 | 649 | 496 | 553 | N/A |
3/31/2023 | 3,972 | 298 | 362 | 422 | N/A |
12/31/2022 | 3,959 | 234 | 591 | 651 | N/A |
9/30/2022 | 3,820 | 240 | 60 | 106 | N/A |
6/30/2022 | 3,644 | 210 | 449 | 500 | N/A |
3/31/2022 | 3,459 | 500 | 1,206 | 1,258 | N/A |
12/31/2021 | 3,495 | 527 | 546 | 597 | N/A |
9/30/2021 | 3,473 | 449 | 1,507 | 1,555 | N/A |
6/30/2021 | 3,449 | 439 | 1,641 | 1,692 | N/A |
3/31/2021 | 3,516 | 447 | 1,848 | 1,895 | N/A |
12/31/2020 | 3,427 | 467 | 1,411 | 1,459 | N/A |
9/30/2020 | 3,182 | 466 | 1,382 | 1,427 | N/A |
6/30/2020 | 3,064 | 462 | 770 | 804 | N/A |
3/31/2020 | 2,816 | 436 | 638 | 678 | N/A |
12/31/2019 | 2,496 | 373 | 598 | 633 | N/A |
9/30/2019 | 2,645 | 424 | 586 | 622 | N/A |
6/30/2019 | 2,546 | 404 | 460 | 503 | N/A |
3/31/2019 | 2,593 | 398 | 454 | 489 | N/A |
12/31/2018 | 2,769 | 422 | 498 | 535 | N/A |
9/30/2018 | 2,642 | 539 | 464 | 504 | N/A |
6/30/2018 | 2,677 | 514 | N/A | 552 | N/A |
3/31/2018 | 2,651 | 499 | N/A | 556 | N/A |
12/31/2017 | 2,229 | 397 | N/A | 374 | N/A |
9/30/2017 | 1,799 | 187 | N/A | 234 | N/A |
6/30/2017 | 1,357 | 168 | N/A | 287 | N/A |
3/31/2017 | 889 | 151 | N/A | 115 | N/A |
12/31/2016 | 703 | 185 | N/A | 230 | N/A |
9/30/2016 | 668 | 190 | N/A | 225 | N/A |
6/30/2016 | 687 | 217 | N/A | 254 | N/A |
3/31/2016 | 662 | 211 | N/A | 264 | N/A |
12/31/2015 | 664 | 204 | N/A | 245 | N/A |
9/30/2015 | 645 | 203 | N/A | 273 | N/A |
6/30/2015 | 607 | 184 | N/A | 247 | N/A |
3/31/2015 | 602 | 182 | N/A | 253 | N/A |
12/31/2014 | 617 | 188 | N/A | 263 | N/A |
9/30/2014 | 593 | 185 | N/A | 236 | N/A |
6/30/2014 | 580 | 178 | N/A | 229 | N/A |
3/31/2014 | 587 | 181 | N/A | 217 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CBOE's forecast earnings growth (6.6% per year) is above the savings rate (2.6%).
Earnings vs Market: CBOE's earnings (6.6% per year) are forecast to grow slower than the US market (14.9% per year).
High Growth Earnings: CBOE's earnings are forecast to grow, but not significantly.
Revenue vs Market: CBOE's revenue is expected to decline over the next 3 years (-9.8% per year).
High Growth Revenue: CBOE's revenue is forecast to decline over the next 3 years (-9.8% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CBOE's Return on Equity is forecast to be high in 3 years time (21.9%)
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/20 00:44 |
End of Day Share Price | 2025/01/17 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cboe Global Markets, Inc. is covered by 33 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Kevin Heal | Argus Research Company |
Roger Freeman | Barclays |
Benjamin Budish | Barclays |